Parexel, JFCR ink agreement to accelerate access to oncology clinical trials in Japan
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 16, 2024
Under […]
Clinical Development Clinical Trials Research Trials 
Leveraging Genetic Testing for Enrolling Rare Disease Trials
Worldwide Clinical Trials
JANUARY 24, 2024
Written By: Derek Ansel, MS, CCRA, Executive Director, Therapeutic Strategy Lead, Rare Disease Given that 80% of rare diseases have a genetic etiology, genetic implications should be addressed at the onset of a clinical program to support trial enrollment. One diagnostic example that I discussed in my presentation is autism.
Genetics 
189
189 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
9 Ways Worldwide Optimizes Clinical Development for Your Biotech Growth Journey
Worldwide Clinical Trials
AUGUST 15, 2023
Selecting the right CRO to partner with on your development program is a pivotal decision that can shape the trajectory of your product’s development. Our consultative approach ensures success by integrating research methodology, regulatory affairs strategy, and clinical operations.
Why Should Companies Use Digital Endpoints Across Clinical Development?
XTalks
MAY 28, 2024
The traditional clinical trials model is facing scrutiny. VivoSense , a pioneering company in the field of digital health technologies (DHTs) and digital endpoints for clinical trials, is aiming to enhance the efficiency and efficacy of clinical research.
Interview: Is global AI regulation really revolutionizing pharma and clinical trials?
Outsourcing Pharma
APRIL 29, 2024
OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.
Clinical Trials 103
103 
Clinical Trials For All Campaign: Converging Trials and Healthcare
XTalks
AUGUST 22, 2023
Recruiting participants is perhaps the most challenging aspect of any clinical trial, regardless of the therapeutic area. Yet this one piece is also the most vital, with a trial’s ability to enroll and retain participants being a key predictor of a study’s future success. What is Clinical Trials For All?
What Are the Top Oncology Clinical Trial Trends Through the Lens of ESMO?
XTalks
JANUARY 17, 2024
Estimates based on publicly available information suggest more than 40 percent of all new therapies in development are cancer treatments. Given this hotbed of activity, innovation in the space to drive faster decisions and more efficient trials is intense.
Clinical Trials 124
124 
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
Pharma Mirror
JUNE 8, 2022
According to the Endpoints ASCO session: “China and the US are the world’s largest oncology research destinations, and the. The post Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China appeared first on Pharma Mirror Magazine.
Clinical Trials 130
130 
10 Trends and Statistics for Clinical Trials in 2023
XTalks
MAY 19, 2023
Clinical trials play a vital role in advancing patient treatment and medical care. This article delves into ten trends and statistics in the world of clinical trials for 2023. Increasing Number of Registered Clinical Trials As of May 17, 2023, there are 452,604 registered clinical trials globally on ClinicalTrials.gov.
How Can Proactive Compliance Transform Quality in Clinical Trials?
XTalks
JULY 9, 2024
In the dynamic landscape of clinical trials, ensuring compliance and maintaining high-quality standards are paramount. The field of quality and compliance in clinical trials is undergoing significant transformations driven by technological advancements, regulatory changes and evolving industry practices.
Compliance 59
59 
The Power of Personalization Amid the Changing CRO Landscape
Worldwide Clinical Trials
DECEMBER 7, 2023
Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. What Differentiates Mid-Size CROs?
Enhancing clinical trial engagement: an exploration with James Riddle of Advarra
Outsourcing Pharma
MARCH 1, 2024
In the dynamic realm of clinical trials, where innovation and patient care intersect, Advarra believes it stands as a beacon of progress, continually revolutionizing how medical research is conducted.
Transforming clinical trials: Medable and Masimo's game-changing partnership unveiled
Outsourcing Pharma
JUNE 3, 2024
In a collaboration set to alter the landscape of clinical trials, Medable Inc. and Masimo have announced a strategic partnership aimed at revolutionizing evidence generation in medical research.
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
XTalks
FEBRUARY 9, 2023
Leading clinical trials technology platform provider Medable announced a new partnership with Nova Scotia Health Innovation Hub for a two-year pilot study to improve oncology trial access for patients in rural Nova Scotia through Medable’s decentralized clinical trial (DCT) platform.
Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials
VirTrial
JUNE 17, 2024
Over the past decades, Myasthenia Gravis (MG) clinical trials have made remarkable progress in shining a light on this debilitating disease. Clinical trials in MG – What does history tell us? With a better understanding of the disease mechanisms, new target treatment options emerged in the 20th century.
Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials
VirTrial
JUNE 17, 2024
Over the past decades, Myasthenia Gravis (MG) clinical trials have made remarkable progress in shining a light on this debilitating disease. Clinical trials in MG – What does history tell us? With a better understanding of the disease mechanisms, new target treatment options emerged in the 20th century.
Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials
VirTrial
JUNE 17, 2024
Over the past decades, Myasthenia Gravis (MG) clinical trials have made remarkable progress in shining a light on this debilitating disease. Clinical trials in MG – What does history tell us? With a better understanding of the disease mechanisms, new target treatment options emerged in the 20th century.
Complexity in Early Phase Clinical Trials with Dr. Oren Cohen?
Clinical Trial Podcast
SEPTEMBER 26, 2022
To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials. Dr. Cohen has more than 30 years of healthcare experience which includes his work on clinical development. Cohen to the Clinical Trial Podcast.
Ora partners with North West London Clinical Trials Alliance to enhance ophthalmology treatments
Outsourcing Pharma
JULY 12, 2023
Ora, a clinical research organization (CRO) for ophthalmology pharmaceutical and device development, has partnered the North West London Clinical Trials Alliance, to improve the quality and access to clinical research in the region.
Interview: Is global AI regulation really revolutionizing pharma and clinical trials?
Outsourcing Pharma
APRIL 29, 2024
OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.
Public Perceptions of Clinical Trials: A Comprehensive Survey
Advarra
AUGUST 14, 2023
The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight deadlines. The clinical trial process is both expensive and time-consuming, and ends more often in failure than success. Advarra surveyed 1,000 random U.S. In total, 82.8%
How precision medicine will transform clinical trials
Drug Discovery World
MAY 17, 2023
Leveraging historical trial databases has become commonplace in assessing the feasibility of trials in therapeutic areas with a large breadth of clinical development history. EHR data also has a key role to play in designing future clinical trials.
Increasing patient engagement with UK clinical trials
pharmaphorum
NOVEMBER 17, 2020
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Improving the design of commercial research by listening to the patient voice.
Clinical Trials 116
116 
Podcast: In conversation with clinical trial experts
Drug Discovery World
JANUARY 17, 2023
In this latest episode, DDW’s Megan Thomas is in conversation with two experts when it comes to clinical trials. Walz was recently selected in the 2022 PharmaVoice 100 for the company’s innovative work in the space, and speaks about how real world data can help to boost diversity rates in clinical trials.
Patient groups issue call to action on patient-centric clinical trials
Drug Discovery World
SEPTEMBER 4, 2023
A new whitepaper has introduced the concept of ‘cross-over’ options in cancer clinical trials, as a way to make trials more patient-centric in design. It also encourages sponsors, investigators and regulators to advance patient-centric trial designs.
Enhancing clinical trial engagement: a deepdive with insights from James Riddle of Medidata
Outsourcing Pharma
MARCH 1, 2024
In the dynamic realm of clinical trials, where innovation and patient care intersect, Medidata believes it stands as a beacon of progress, continually revolutionizing how medical research is conducted.
Exclusive expert insights into clinical trials
Drug Discovery World
JANUARY 17, 2023
In this latest episode, DDW’s Megan Thomas is in conversation with two experts when it comes to clinical trials. Walz was recently selected in the 2022 PharmaVoice 100 for the company’s innovative work in the space, and speaks about how real world data can help to boost diversity rates in clinical trials.
Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials
VirTrial
JUNE 17, 2024
Over the past decades, Myasthenia Gravis (MG) clinical trials have made remarkable progress in shining a light on this debilitating disease. Clinical trials in MG – What does history tell us? With a better understanding of the disease mechanisms, new target treatment options emerged in the 20th century.
Increase in diabetes research fuelled by GLP-1s like Ozempic
Drug Discovery World
JULY 12, 2024
Covid-19 is no longer in the top five most studied indications, replaced by type 2 diabetes, according to Phesi’s mid-year analysis of clinical trials. The analysis of 66,935 clinical trials reveals that the top five most studied diseases are now breast cancer, solid tumours, stroke, prostate cancer and type 2 diabetes.
Research 59
59 
Interview: Issues in data-monitoring for complex clinical trials
Outsourcing Pharma
NOVEMBER 29, 2023
OSP enjoyed a discussion with both her and Professor Jennifer Visser-Rogers, vice-president for statistical research and consultancy at Phastar, about how new approaches to clinical trials are changing data monitoring committees.
Reimagining CRO Partnerships: The Emerging Preference for Midsize Organizations
Worldwide Clinical Trials
APRIL 15, 2024
As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs.
Clinical Trials 130
130 
Enhancing Lupus Clinical Trials with Real-World Data Sources
XTalks
JANUARY 17, 2024
Lupus, a complex autoimmune disease, has brought a substantial challenge to researchers and healthcare professionals. Understanding this condition and its various manifestations, as well as developing effective treatments, has been the focus of ongoing investigation in lupus clinical research for many years.
IQVIA’s report card for clinical trial diversity: must do better
pharmaphorum
NOVEMBER 11, 2022
The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. Both groups were poorly represented however in oncology trials. for Hispanics.
Demonstrating Clinical Trial Competencies
ACRP blog
DECEMBER 22, 2022
While demand for skilled clinical research professionals is at an all-time high, identifying candidates with the required skill sets is challenging. Over the last 10 years, there’s been a huge push for the clinical research industry to work toward professional competency and credentialing, with a vast influx of programmatic education.
Clinical Trials Day 2021: Reflecting on a Challenging Year That’s Made the Industry Stronger
XTalks
MAY 20, 2021
Today is Clinical Trials Day 2021 — a day for recognizing the importance of clinical research in protecting and improving global health. Amid the alarmist headlines posted by other media outlets, Xtalks has remained balanced in its reporting of COVID-19 clinical trial results and safety data.
Clinical Trials 105
105 
Diversity in clinical trials has actually dropped since 2012, IQVIA finds
Outsourcing Pharma
MARCH 20, 2023
Despite diversity being spoken about more than ever before, research discovers clinical trials are less representative of the US population compared to a decade prior.
6 Principles of Our Rare Disease Methodology That Drive Success for Our Sponsors
Worldwide Clinical Trials
MAY 14, 2024
By: Amy Raymond, Derek Ansel, Nathan Chadwick, & Juliane Mills When choosing a CRO for a rare disease study, what truly sets them apart is their methodology: the CRO’s mindset, their approach to each unique study, and their agility in navigating the inherent complexities of rare disease research. Engage stakeholders EARLY.
Trials 204
204 
Navigating the Global Clinical Landscape: CTA or IND for Your First-in-Human Study?
Worldwide Clinical Trials
MARCH 7, 2024
When conducting first-in-human (FIH) clinical trials, small to midsize pharmaceutical and biotechnology companies are faced with several crucial choices that can shape the trajectory of their drug development pathway. The post Navigating the Global Clinical Landscape: CTA or IND for Your First-in-Human Study?
Clinical Trials 130
130 
Perfusion MRI and Other Perfusion Imaging Techniques for Clinical Trials
XTalks
OCTOBER 12, 2022
Magnetic resonance imaging (MRI) has had a part in clinical trials for more than three decades now. However, the role of MRI in new drug clinical trials can involve diagnosis of lesions and determination of their severity, early identification of therapeutic responders to drug treatment and treatment monitoring and follow-up.
Cancer Research UK and UCB advance oncology antibody candidates
Drug Discovery World
MARCH 10, 2023
Cancer Research UK and UCB have agreed a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials. The post Cancer Research UK and UCB advance oncology antibody candidates appeared first on Drug Discovery World (DDW).
Antibody 98
98 
Thermo Fisher launches decentralized clinical trial network
Outsourcing Pharma
OCTOBER 17, 2022
The company, through its subsidiary, PPD, announced that it had created a network that would provide learning materials to those investigators and research sites looking to use decentralized clinical trials (DCTs) for drug development.
Clinical Data Management Experts Share Insights on Modern Digital Clinical Trials
XTalks
MAY 6, 2022
In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. In addition, 43.4 percent were using or piloting omics data.
A 360-degree View on Motivators and Deterrents to Clinical Trial Participation
WCG Clinical
SEPTEMBER 11, 2023
Listen and Subscribe: Apple PodCASTs Spotify Google PoDCASTS About this episode: In episode three of WCG Talks Trials , two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report , which provides a 360-degree view on motivators and deterrents to clinical trial participation. Gina DiCindio: Sure.
How Alexion is Turning Patient Feedback into Actionable Insights in Rare Disease Clinical Trials
XTalks
MAY 11, 2023
Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Wendy: RARE-X is now the data and research arm of Global Genes, the flagship patient organization representing rare, ultra-rare, and “n-of-one” patients.
Let's personalize your content